MLTX
NASDAQ
CH
MoonLake Immunotherapeutics - Class A Ordinary Shares
$17.36
▲ +$0.84
(+5.08%)
Vol 1.7M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$940.7M
ROE
-56.3%
D/E
25.52
Beta
1.21
52W
$6–$63
Wall Street Consensus
23 analysts · Apr 20268
Strong Buy
10
Buy
3
Hold
1
Sell
1
Strong Sell
78.3%
Buy Rating
Price Chart
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.92
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.92 | — | — |
| Dec 2025 | $-1.01 | $-0.92 | +$0.09 |
| Sep 2025 | $-0.90 | $-1.10 | $-0.20 |
| Jun 2025 | $-0.74 | $-0.87 | $-0.13 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -41.5% | -41.5% | -41.5% | -41.5% | -56.2% | -56.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 20.74 | 20.74 | 20.74 | 20.74 | 25.52 | 25.52 |
| Current Ratio | 16.65 | 16.65 | 16.65 | 16.65 | 8.50 | 8.50 |
Key Ratios
ROA (TTM)
-45.2%
P/B
7.7
EPS (TTM)
$-3.33
CF/Share
$-1.19
52W High
$62.75
52W Low
$5.95
$5.95
52-Week Range
$62.75
How does MLTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MLTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
7.7
▲
215%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MLTX profitability vs Biotechnology peers
ROE
-56.3%
▲
16%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-45.2%
▲
3%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
MLTX financial health vs Biotechnology peers
D/E ratio
25.5
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
8.5
▲
91%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▲
24%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
MLTX fundamentals radar
MLTX
Peer median
Industry
MLTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MLTX vs peers: key metrics
Latest News
No related news yet